Evidence map›Paper›PMID 28405401›Full record

ArticleRoyal Society open science2017

Sergio Casas-Tintó, Mercedes Arnés, Alberto Ferrús

Open access · goldAbstract read
In one paragraph

Article in Royal Society open science, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 26 papers.

0numbers the graph read from it
0cells of the map it votes in
26citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

26 citing papers in PubMed, 48 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. VP3.15, a dual GSK-3β/PDE7 inhibitor, reduces glioblastoma tumor growth though changes in the tumor microenvironment in a PTEN wild-type context.Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Tissue-specific knockout inbioRxiv : the preprint server for biology · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Review
  15. Circadian GeneInternational journal of molecular sciences · 2022
    Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 2 countries.

Sergio Casas-TintóCajal Institute -CSIC, Ave. Doctor Arce 37, Madrid 28002 , Spain.ORCID 0000-0002-9589-9981
Mercedes ArnésCajal Institute -CSIC, Ave. Doctor Arce 37, Madrid 28002 , Spain.
Alberto FerrúsCajal Institute -CSIC, Ave. Doctor Arce 37, Madrid 28002 , Spain.
Google (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In

Indexed as

developmentDrosophilaGal4gene expressionneuroscience

Identifiers

PMID28405401
PMCPMC5383858
OpenAlexW2602567272

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.